期刊文献+

维生素E琥珀酸酯对乳腺癌荷瘤裸鼠的抑瘤作用 被引量:3

Inhibitory effect of vitamin E succinate on experimental breast cancer in nude mice
下载PDF
导出
摘要 目的检测维生素E琥珀酸酯(VES)对裸鼠荷乳腺癌MCF-7细胞的抑制作用。方法裸鼠皮下接种MCF-7乳腺癌细胞建立荷瘤裸鼠模型。以1 5 0mg/kg(体重)剂量的VES治疗模型鼠共5周。处死动物后测量肿瘤大小。以流式细胞仪检测细胞周期变化和细胞表面Fas和FasL的表达;以免疫组化法检测肿瘤组织Fas和FasL的表达,并以TUNEL法检测细胞凋亡指数。结果VES对荷乳腺癌裸鼠具有显著的增殖抑制作用。细胞周期分析显示,VES治疗后肿瘤细胞表现为G0/G1期阻滞,肿瘤组织和细胞表面的Fas和FasL均出现上调,同时细胞的凋亡指数升高。结论VES对于MCF-7乳腺癌荷瘤裸鼠具有强效的抑制作用,其机制与上调肿瘤细胞Fas/FasL表达,促进细胞凋亡有关。 Objective To investigate the inhibitory effect of vitamin E suceinate ( VES ) on experimental breast cancer in nude mice. Methods MCF-7 human breast cancer cells were inoculated subeutaneously in nude mice. VES was administrated at a dosage of 150mg/kg body wweight for 5 weeks. Then, the size of the tumor was measured and cell cycle and cell surfaee Fas/Fasl, were detected by flow cytometry. Fas/FasL expression in tumor tissue was detected with immunohistochemistrv , and apoptosis index was detected by TUNEL method. Results VES showed obviously inhibitory eftect on the growth of graft breast cancer tumor in viro . VES treatment blocked tumor cells in G0/G1 phase. Fas/FasL expression was up-regulated accompanied with a rise of apoptotic index in tumor tissue. Conclusions VES had potent inhibitory effect on MCF-7 breast cancer graft in nude mice. The mechanism involved may be related to the up-regulation of Fas/FasL expression and promotion of apoptosis of tumor cells.
出处 《中国普通外科杂志》 CAS CSCD 2005年第12期918-921,共4页 China Journal of General Surgery
基金 上海市科委科技发展基金资助(024119105)
关键词 琥珀酸酐类/病理学 乳腺肿瘤/药物疗法 MCF-7 Succinie Anhydrides/pathol Brease Neoplasms/drug ther MCF-7
  • 相关文献

二级参考文献2

共引文献28

同被引文献30

  • 1张伟,徐昕昀,张军初,朱大乔,张玲珍,王强.维生素E琥珀酸酯诱导MDA-MB-435乳腺癌细胞的凋亡[J].肿瘤,2006,26(4):318-321. 被引量:5
  • 2申郑堂,罗沙阳,王守满,邬玉辉,欧慧英,海健.乳腺癌哨兵淋巴结转移与肿瘤大小和癌基因及激素受体表达关系的临床观察[J].中国普通外科杂志,2006,15(10):728-731. 被引量:10
  • 3Toker A, Yoeli-Lemer M. Akt signaling and cancer: surviving but not moving on[J]. Cancer Res, 2006,66(8) : 3963-3966.
  • 4Stambolic V, Woodgett JR. Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration [ J ] . Trends Cell Biol, 2006,16 ( 9 ) : 461 - 466.
  • 5Kirkegaard T, Witton C J, McGlynn LM, et al. AKT activation predicts outcome in breast cancer patients treated with tamoxifen[J]. J Pathol, 2005,207(2):139-146.
  • 6Cantley LC. The phosphoinositide 3-kinase pathway [ J ]. Science, 2002 , 296 ( 5573 ) : 1655 - 1657.
  • 7Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy [ J ]. Cell Signal, 2002,14(5) :381 -395.
  • 8Gao N, Flynn DC, Zhang Z, et al. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/ AKT/MTOR/P70S6K1 signalling in human ovarian cancer cells[J]. Am J Physiol Cell Physiol, 2004, 287 (2) : C281 -291.
  • 9Arboleda M J, Lyons JF, Kabbinavar FF, et al. Overexpression of AKT2/protein kinase beta leads to up-regulation of beta 1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells [ J ] . Cancer Res, 2003 , 63 (1):196-206.
  • 10Tokunaga E, Kataoka A, Kirnura Y, et al, The association between Akt activation and resistance to hormone therapy in metastatic breast cancer [ J ]. Euro J Cancer, 2006, 42 (5) :629 -635.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部